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Abstract  
The purpose of this study is to examine how life expectancy, as a measure for health, 
affects economic growth in Sub-Saharan Africa. Furthermore, the model specifications 
in this thesis include AIDS, which is assumed to have an exogenous effect on life 
expectancy. This effect is in turn regarded as a natural experiment for life expectancy. 
An econometric model, based on the Solow growth model and previous research, is 
constructed. The data covers 16 sample countries across Sub-Saharan Africa between 
the years 1990-2017. Life expectancy at birth is the variable of interest, proxying the 
effect of health, which is presumed to be exogenously affected by AIDS-related deaths. 
AIDS-related deaths is also included as a variable of interest, to investigate if the 
epidemic alone affected economic growth, and not solely through its assumed effect on 
life expectancy. Additional control variables, which are all related to economic growth, 
are included to minimize omitted variable bias. Results from the model show that there 
is indeed a statistically significant relationship between life expectancy at birth and 
GDP growth. However, the findings show that inference regarding the direct effect of 
AIDS-related deaths on the dependent variable could not be drawn, as it was estimated 
as insignificant. The study concludes that the reduced life expectancy, seen during the 
AIDS epidemic, has had a negative impact on GDP growth in Sub-Saharan Africa. 
Given the assumptions about AIDS exogenous effect on life expectancy, this would 
imply that without the negative effect of AIDS on life expectancy, the economic growth 
in Sub-Saharan Africa would not have been as impeded.  
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1. Introduction 
Health is acknowledged as being a key feature for human- and economic development (World 
Health Organization, 2019). Public health is commonly found to be poor in low developed 
countries, which includes major parts of Africa. In 2016, the second largest cause of death in 
Africa was AIDS, after lower respiratory infections (WHO, 2016). Even though both of these 
causes are health related, an important difference to emphasize is that the latter mainly affects 
children and elderly, whereas HIV/AIDS affects the entire population, including the working-
age cohorts.  
      
Many countries in Sub-Saharan Africa struggle greatly with HIV/AIDS, it is the region where 
the largest number of people infected by HIV live. From 1990 and a few years into the 21st 
century, when the HIV/AIDS epidemic was at its peak, life expectancy at birth decreased with 
roughly 20% in countries such as Botswana, Eswatini and South Africa (World Development 
Indicators, 2019). The number of HIV infected people relative to AIDS victims continues to 
increase, a consequence of the improved access to antiretroviral treatment (ART) which both 
improves lives and has caused a grand reduction in the number of AIDS-related deaths (Avert, 
2017). The access to antiretroviral treatment is also expected to be the main reason for the 
increase in life expectancy in the 21st century. In conclusion, during the most severe years of 
AIDS, life expectancy decreased. Later, when ART was introduced, life expectancy increased. 
An exogenous effect of AIDS on life expectancy is therefore assumed in this thesis which 
makes the effect of AIDS-related deaths on life expectancy an applicable natural experiment, 
further discussion regarding the exogeneity of the effect is found in section 2.2.   
 
Sub-Saharan Africa is a region characterized by low economic development, corruption and 
conflicts, making it sensitive to shocks, such as epidemics. By using the assumed exogenous 
effect that the AIDS epidemic has had on life expectancy at birth, this thesis aims to study if 
life expectancy has affected economic growth in 16 selected Sub-Saharan countries (table 1). 
      
One study analyzing the relationship between health and economic growth is written by 
Lorentzen, McMillian and Wacziarg (2005). They looked at how adult mortality affects 
economic growth of income per capita and found that adult mortality changes behaviour in 
ways which disfavour growth. Another study regarding health by Acemoglu and Johnson 
(2007) investigated the effect health improvements has had on economic growth. Due to 
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omitted disadvantages the authors claimed that causality between health improvements and 
growth cannot be established. The authors did nonetheless state that since AIDS affects 
productive adults it is likely to have a negative effect on growth. However, studies specifically 
examining the effect AIDS has had on economic growth show varying results. For instance, 
Over (1992) estimated a comparison between scenarios with and without AIDS from 1990 to 
2040 to investigate if the epidemic would have a macroeconomic effect. Over aimed to find 
out if the epidemic affected GDP per capita in other aspects than population growth rate 
reduction, which alone would increase GDP per capita. The author concluded that AIDS has 
had a substantial negative impact on economic growth.  
 
The net effect of the AIDS epidemic on the growth of per capita GDP is a 
reduction of about a third of a percentage point in the ten countries with the 
most advanced epidemics. This is a substantial impact in countries that have 
been struggling to escape from a period of negative growth rates. (Over, 1992, 
p. 1).  
 
In strong contrast, Alwyn Young (2005) studied the effect AIDS would have on the future 
standards of living. The author found that due to the decreased population growth rate the 
region would be left with a relative redundancy of resources, which would increase future 
consumption and thereby affect economic growth positively.  
 
Although several studies looking at the relationship between economic growth and HIV/AIDS 
have been conducted through the years, most of these have focused on either a relatively 
concise time frame or on a rather limited country subset. In addition, the studies have generally 
regarded the sum of HIV-infected people as the variable of interest and have chosen control 
variables which are mainly correlated with the effectiveness of health care, e.g. human capital 
measures (Dixon, McDonald, & Roberts, 2001; Kahende & Hoch, 2008; Bloom & Mahal, 
1997). This thesis on the other hand investigates the economic impact of AIDS-related deaths 
relative to the labour force and controls for variables assumedly associated with Gross 
Domestic Product (GDP) growth.  
 
Numerous studies regarding the relationship between AIDS and GDP growth were published 
during the most severe time of the epidemic, from 1990 until early 2000. The introduction of 
antiretroviral treatment in 1997 changed the situation dramatically by reducing the number of 
AIDS-related deaths (Avert, 2017). The impact of the antiretroviral drug was deferred and the 
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effect on life expectancy can first be observed in the 21st century. Investigating the relationship 
between AIDS and GDP growth today, in 2019, would therefore probably give different results 
since it is now possible to observe the increase, peak and decline of the epidemic, including the 
effect from the introduction of ART.  
 
The purpose of this thesis is to examine how life expectancy at birth, as a measure for health, 
has affected economic growth in Sub-Saharan Africa. The assumed exogenous effect of AIDS 
on life expectancy is used as a natural experiment. We conduct a panel data analysis with the 
Solow growth model as a foundation to achieve the purpose of the thesis. To reach a conclusion 
the following research question will be answered.  
 
● Does life expectancy, as a measure for health, have an impact on economic growth in 
Sub-Saharan Africa?  
 
The thesis proceeds as following; Firstly, a background of HIV/AIDS, an introduction to the 
economic theory used and a brief literature review. Secondly, a description of the data and the 
method used to analyse the data. Thereafter, results of the regressions and econometric model 
and a sensitivity analysis are presented, followed by a discussion including an analysis of the 
results. Lastly, the conclusion, answering the research question is presented, followed by the 
references and appendix.  
2. Background 
2.1 Background on HIV/AIDS  
HIV was first documented as an upcoming epidemic in the late 1970’s and by the 1980’s HIV 
was estimated to have spread to five continents. The following decade, in the 1990’s, the virus 
quickly advanced and was found to be the cause of AIDS (Avert, 2017). The virus increased 
rapidly worldwide until the peak year of 1997. After years of research on a treatment for the 
virus, 1996 marked the beginning of the era of Highly Active Antiretroviral Therapy. A year 
later, in 1997, the first combination antiretroviral pill was approved, which massively improved 
HIV treatment (Avert, n.d.). This is the course of the HIV/AIDS epidemic which will be 
analysed in the thesis, starting when the epidemic escalated in 1990, increasing until its peak 
year of 1997 and thereafter declining due to antiretroviral treatment.  
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In Sub-Saharan Africa, the virus hit catastrophically, and today in 2019 it is still a highly topical 
issue globally. Sub-Saharan Africa is home to approximately 50% of the total number of people 
infected by HIV in the world. The number of HIV infected people is continuously increasing 
in Sub-Saharan Africa, although the yearly number of AIDS-related deaths (ARD) has 
decreased from 760,000 in 2010 to 420,000 in 2016 (Avert, 2017).  
 
Figure 1 illustrates the AIDS-related deaths for each of the sample countries from 1990-2017, 
as a share of labour in percent. For most of the countries, the figure shows the escalation of 
AIDS-related deaths until the beginning of the 21st century, followed by the subsequent decline 
as described above.  
 
Figure 1: AIDS-related deaths/Labour in %, 1990-2017.  
 
HIV/AIDS has certainly had a negative social impact on the countries severely affected. There 
is however also some evidence that the deaths that followed the epidemic decreased life 
expectancy at birth (appendix table A2), which consequently is expected to have had an impact 
on GDP growth. Figure 2 illustrates how life expectancy at birth changed in each of the sampled 
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Sub-Saharan countries during the studied time period. The figure shows a decline in life 
expectancy for several of the sample countries from 1990 until the beginning of the 21st 
century, after that, it starts to increase.  
      
 
Figure 2: Life expectancy at birth (1990-2017) 
 
In Botswana during the worst years of the AIDS epidemic, life expectancy at birth declined 
from nearly 62 years in 1990, to 49 years in 2001. It then increased, probably in part due to the 
introduction of antiretroviral treatment, reaching 67 years in 2017. In Uganda, the decline in 
life expectancy during the studied time period was not as severe as in Botswana. The country 
did however experience a decline from 45,5 years to 44,2 years between 1990 and 1995, and 
then an escalation to 60 years in 2017 (World bank, 2019).  
 
Figure 3 shows the negative relationship between life expectancy at birth (vertical axis) and 
AIDS-related deaths (horizontal axis) in 6 of the sample countries. There is a negative 
correlation for all the countries seen in figure 3, though not in equal magnitude, as also 
explained when comparing Botswana and Uganda. The relationship provides some evidence 
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that the assumed exogenous effect of ARD is an appropriate natural experiment to estimate 
how changes in life expectancy at birth affect economic growth.  
      
 
Figure 3: Life expectancy at birth (in number of years lived) on ARD (number of deaths).  
2.2 AIDS as a natural experiment  
In this thesis, the AIDS epidemic in Sub-Saharan Africa will be used as a natural experiment 
due to the exogenous effect we assume it has on life expectancy at birth. We analyse life 
expectancy during the most severe years of the AIDS epidemic and assume that AIDS is a main 
reason behind the decline in life expectancy at birth. The latter increase is assumed to be a 
consequence of AIDS-related deaths being reduced because of ART. This is an assumption 
made for this thesis, it does not ascertain that the effect is exogenous since many other factors 
could have affected life expectancy. Politically unstable countries are excluded from the sample 
(see section 4.2) to minimize the effect on life expectancy caused by for example conflicts. 
Still, a more country specific analysis would have to be made to be able to claim causality 
between ARD and life expectancy at birth and to assure an exogenous effect of AIDS on life 
expectancy.  
      
The effect of AIDS is not a perfect natural experiment due to the possibility of endogeneity, 
we do however make the assumption of an exogenous effect of AIDS on life expectancy. The 
assumption is made with awareness of the limitations to the experiment and therefore also the 
accuracy of the results.  
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When analysing AIDS and economic growth, endogeneity and reversed causality cannot be 
ruled out. Even though AIDS is a disease which affects high-income countries as well as low-
income countries, exogeneity cannot be assured in the regression analysis. In low developed 
countries, as this thesis studies, information about the spread and treatment is poor. In high-
income countries on the other hand, medication and information is well-known and accessible, 
giving these countries a better basis to impede the AIDS epidemic. There is an endogeneity 
issue present since the ability to manage an epidemic is an important factor which affects the 
number of AIDS victims. The fact that countries in Sub-Saharan Africa struggle to access 
antiretroviral treatment due to insufficient funds is an important reason why reversed causality 
is also possible. This would mean that the dependent variable, economic growth, affects the 
independent variable, AIDS-related deaths. Due to this dilemma of reversed causality and 
endogeneity between AIDS and economic growth, causality cannot be established. 
Nonetheless, regressions using ARD as the variables of interest will be conducted to evaluate 
if it does have any significant effect on economic growth directly, and not only through the 
assumed effect on life expectancy. As stated, this will be analysed cautiously and with respect 
to the limitations that follow when exogeneity cannot be assured.  
 
The variable which will be used when estimating the effect of AIDS is AIDS-related deaths 
(ARD). The rationale behind choosing ARD instead of looking at HIV prevalence mainly 
relates to the earlier mentioned introduction of antiretroviral treatment in the late 1990, which 
completely altered the standards of living for HIV-victims in two ways. First off, it stops the 
virus from developing to AIDS, consequently decreasing mortality rates. Simultaneous to this, 
it also decreases morbidity amongst the infected (WHO, 2019; U.S National Library of 
Medicine, 2016). The introduction of ART would naturally skew any regression results 
including HIV/AIDS-victims as a variable and concurrently make it difficult to extrapolate the 
effect with the dependent GDP-variable, hence the variable ARD is used instead. By doing so, 
the endogenous ART-effect is minimized and made more exogenous to the model, improving 
inference on the results.  
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3. Theoretical framework 
3.1 Solow growth model  
The textbook Solow growth model is centred around the production function, using only two 
key inputs to explain economic growth, capital and labour. The output, growth, increases with 
both the variables, and the function is seen to be subject to the law of diminishing marginal 
productivity. Below (equation 1) is the expression for the Solow model where the output 
growth Y, is a function f of the inputs, capital K, human capital H, productivity A, and labour 
L, where AL gives the productive labour force, as specified by Acemoglu (2011).  
 
(1)     𝑌 = 𝑓(𝐾,𝐻, 𝐴𝐿) 
 
Human capital H represents health in our thesis, health is in turn captured by the measure for 
health, life expectancy at birth. The variable AIDS-related deaths is, through its assumed effect 
on life expectancy therefore affecting H. Education is also commonly included in human 
capital, but due to data limitations it is not accounted for. Not accounting for education is a 
deficiency with the thesis since AIDS possibly affected education as well. It is likely that for 
example, attendance from both students and teachers decreased during the worst years of the 
epidemic.  
 
The Solow model includes technology/productivity A as a key variable for growth, a part not 
explained by changes in capital or labour. Productivity improvement, usually through 
exogenous technological breakthroughs, is the way to achieve long term growth since this is 
what drives A, according to the model. With constant productivity improvement, the growth 
rate will not return to previous steady state, as it would by changing labour or capital, instead 
it will shift the steady state upwards which generates long term growth. This thesis does not 
analyse the steady state or long term growth, technology will therefore be accounted for as 
exogenous in our model and A will be assumed as a constant.  
 
The following Cobb-Douglas production function (equation 2) will be used to explain how 
growth has been affected by the changing life expectancy at birth in Sub-Saharan Africa, which 
is assumed to have been reduced by AIDS and then improved by the introduction of ART. 
When applying the production function in this thesis Y represents economic growth, K is the 
capital formation, H represents life expectancy or ARD, A is accounted for as exogenous and 
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L is the total labour force. We analyse the cross-country dimension i, and the cross-temporal 
dimension t. The applied model will be further presented in section 5.3.  
 
(2)     𝑌+, = 𝐾+,-𝐻+,.𝐴𝐿+,/0-0.  
 
 
Acemoglu (2013) claimed that the Solow model is an efficient framework for proximate causes 
of growth, but that the model does not look at fundamental causes which underlie the proximate 
causes. This thesis aims to investigate if the changes in life expectancy at birth in Sub-Saharan 
Africa have had an impact on growth. Hence, the proximate causes for growth that the Solow 
growth model provides are adequate for the intention of this thesis.  
3.2 Literature review  
This section reviews earlier studies within our research area. Beginning with studies regarding 
the relationship between health and economic growth, followed by studies specifically on 
HIV/AIDS and economic growth.  
  
Lorentzen, McMillian and Wacziarg (2008) investigated how adult mortality affects growth by 
examining the partial correlations between economic growth of income per capita with various 
measures for mortality. To analyse the cross-country data and the cross-sectional data for India, 
OLS regressions were conducted as well as an extended version which included a dummy 
variable for Sub-Saharan Africa.  
 
Lorentzen, et al. (2005) studied three channels through which adult mortality affects economic 
growth; investment, human capital accumulation and fertility rate. The authors found that adult 
mortality causes people to change their behaviour in ways which disfavour growth. Investment 
rates and human capital accumulation decline while fertility increases, subsequently children 
increase in numbers yet quality, as measured by human capital accumulation, is on average 
lowered. All these three channels generally have a negative impact on economic growth. The 
authors claimed that adult mortality in Africa is a poverty trap and that in a statistical sense it 
can even account for the entire growth tragedy in Sub-Saharan Africa from 1960 to 2000.  
 
Bloom and Canning (2008) explored the links between demographic change and economic 
growth. The econometric approach adopted was fundamentally the production function. Bloom 
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and Canning found that reductions in child- and infant mortality rate will lead to a reduction in 
fertility rate and subsequent reduce the dependency ratio. The dependency ratio is the ratio 
between the non-working-age cohort (0-14 years old and 65 years old and older) and the 
working-age cohort (15-64 years old) which defines the age structure of a region and is useful 
to estimate the burden the working-age cohort carries.  
 
Given that the country is able to absorb the increased labour they can achieve demographic 
dividend from a low dependency ratio. The demographic dividend is a state of high labour-
force participation and high savings rate, which has positive impacts on economic growth and 
will possibly encourage further investments in education (Bloom & Canning, 2008).  
 
Acemoglu and Johnson (2007) estimated the impact health improvements has had on economic 
growth from 1940. The authors referred to earlier studies (Bloom & Sachs, 1998; Gallup & 
Sachs, 2001; WHO, 2001; Alleyne & Cohen, 2002; Bloom & Canning, 2005; Lorentzen, 
McMillan, & Wacziarg, 2005) which all share a consensus that improving health is more than 
a social objective, it also has a positive effect on economic growth. Acemoglu and Johnson on 
the other hand, claimed that the previous studies, showing a strong correlation between health 
measurements and economic growth, have not established a causal effect between diseases and 
GDP growth since other omitted factors have not been accounted for.  
 
Since countries suffering from short life expectancy and ill health are also 
disadvantaged in other ways (and often this is the reason for their poor health 
outcomes), such macro studies may be capturing the negative effects of these other, 
often omitted, disadvantages. (Acemoglu and Johnson, 2007, p. 926) 
 
The authors reached the conclusion that increasing life expectancy cannot be proven to lead to 
faster economic growth of income per capita. They thereby also claimed that it is doubtful that 
health improvements have an important role in increasing economic growth.  
 
In 1940, the major mortal diseases that Acemoglu and Johnson focused on, mainly affected 
children. The authors explicitly stated that the result of the study could be different if they had 
investigated a time of HIV prevalence. Since HIV/AIDS affects the working-age cohort as 
well, the virus would likely have a negative impact on economic growth (Acemoglu & Johnson, 
2007).  
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In a study regarding HIV/AIDS and economic growth, Lovász and Schipp (2009) tested the 
hypothesis that HIV had a sustainable negative impact on economic growth rate per capita in 
Sub-Saharan Africa. The authors used health capital as a determinant of human capital, a 
variable postulated to be a consequence of material standard of living, health care expenditures 
and the incidence of contagious diseases. Lovász and Schipp reached the conclusion that HIV 
prevalence has had a significant negative impact on GDP per capita. Sub-Saharan Africa had 
on average an HIV prevalence rate of 5% and the economic growth rate was reduced by over 
two percentage points each year. Hence, in a scenario without HIV prevalence the region is 
likely to have had a growth rate more similar to South and East Asia. The authors therefore 
claimed that their hypothesis was true and that HIV/AIDS caused a negative impact on growth 
and that this negative effect has been sustainable in Sub-Saharan Africa.  
 
Dixon, McDonald and Roberts (2001) tested the hypothesis if epidemics, such as AIDS, show 
any correlation with growth. In other words, if the effect is spuriously either positive or 
negative. Contrary to their hypothesis, the results from their econometric data analysis clearly 
demonstrate how the epidemic, during the latter so-called peak stage where the loss of lives 
start to impact social and economic interactions, has had a significant effect on economic 
development. Up until reaching that stage however the hypothesis was confirmed, as a clear 
correlation between HIV and economic development could not be established.  
 
Alwyn Young (2005) simulated the effects AIDS will have on the future standards of living in 
Africa. The author referred to a Solow based model in his analysis regarding population growth, 
and behavioural models, to analyse how the behaviour of households change when facing a 
health crisis. Two competing effects are emphasized, fertility and human capital accumulation, 
between which Young found that fertility is the dominant effect on the future standards of 
living. The effect on fertility is negative, subsequently the population growth rate naturally 
declined which improves the dependency ratio. The author stated that the negative effect on 
population growth has endowed the region with extra resources which creates expectations on 
a future increase of consumption and therefore also of economic growth. Young concluded his 
article by clarifying that AIDS has been a humanitarian disaster, however not an economic one, 
seeing as the effect on economic growth was shown to be positive.  
 
Among the studies presented, there is clearly no consensus regarding the effect HIV/AIDS, and 
health in general, has had on economic growth. The main mechanisms through which the 
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authors consider health influences economic growth are changes in productivity, behaviour and 
demography. On one hand, population is decreased and there are less people to share the 
resources with. On the other hand, the working-age cohort is reduced which decreases 
productivity. Which out of these effects is the dominant one in our model, will be estimated 
when reaching the result of how life expectancy, as a measure for health, affects economic 
growth.  
4. Data     
4.1 Data source  
The data used in this study is mainly retrieved from the World Development Indicators (2019), 
assembled by the World Bank, the International Monetary Fund (IMF) (2019), and UNAIDS 
(2018). The cross-country data for the following variables have been collected from the World 
Development Indicator; life expectancy at birth, GDP (constant LCU), GDP (World growth 
%), total labour force, and gross fixed capital formation.  
 
For the AIDS-related deaths the data was collected from UNAIDS (2018) and the commodity 
prices have been retrieved from the IMF (2019). Due to lack of data on commodity prices for 
Botswana and Eswatini from 1990 to 2000, these years have been approximated by using the 
same percentage change of a comparable country as a proxy. Togo is used as a proxy for 
Eswatini, as both these countries are highly dependent on cotton exports, and Namibia is used 
as a proxy for Botswana since both mainly export diamonds (Globalis, 2013-2018).  
4.2 Sample countries and time frame 
The observations span from 1990-2017, a wide span which has the advantage of clearly 
illustrating the entire course of the HIV/AIDS epidemic, starting from a low point and 
expanding until reaching a peak period. This period is then followed by a clear stalled decline 
in AIDS-related deaths after the introduction of antiretroviral treatment plans for HIV-victims 
(Figure 1). By including these transitions in the course of the epidemic, the explicit effect of 
the changes in life expectancy, through the effect of ARD, on economic growth is made 
applicable to our model.  
 
 16 
According to the UN Development Program (2013) 46 African countries are considered Sub-
Saharan, out of these the sample for this thesis contains the following 16 countries: Botswana, 
Burkina Faso, Cameroon, Côte d'Ivoire, Eswatini, Gabon, Kenya, Malawi, Mozambique, 
Namibia, Nigeria, Rwanda, South Africa, Tanzania, Togo & Uganda (table 1).  
 
Due to shortcomings in reported data the following nations have been eliminated from the 
study: Angola, Equatorial Guinea, Eritrea, Ethiopia, Gambia, Guinea Bissau, Lesotho, Liberia, 
Sudan and Zambia. Neither have the smaller islands been analysed, such as Cape Verde, 
Comoros, Mauritius, Sao Tome and Principe, and Seychelles. 
 
To isolate the effect ARD has had on life expectancy, and in turn, economic growth, Burundi, 
Central African Republic, Congo Democratic Republic, Somalia, South Sudan and Zimbabwe 
are not included due to e.g. civil wars and general political- and economic instability during 
the period of observation (Fragile State Index, n.d.).  
 
Lastly, several countries were excluded due to low aggregated ARD during the studied period 
of time. The reason for this is that the scale of the effect on the dependent variable is otherwise 
limited, making it difficult to relate any change in ARD to changes in the economic growth. 
For a generalized epidemic, the HIV prevalence rate is typically over 5% in subpopulations 
whilst remaining below 1% in the general population (UNAIDS 2011). Low is in this thesis 
therefore defined, in line with the definition of a generalized epidemic, as an aggregated sum 
of 5% ARD relative to the total labour force in the respective country. Equation 3 shows that 
countries with an aggregated sum of ARD divided by labour above, or equal to, 0.05 for the 
total time period (1990-2017) are included, where t represents each individual year. This 
excludes Benin, Chad, Congo, Ghana, Guinea, Madagascar, Mali, Mauritania, Niger, Senegal 
and Sierra Leone from the sample (World Bank Indicators & UNAIDS). The countries which 
lie above the 5% limit, and which were neither excluded due to lack of data nor instability, are 
presented in table 1 with their respective aggregated percentages.  
 
(3)    0.05 ≤ Σ+6,7 89:;<8=>?9, + 89:;AB<8=>?9,C/ +,… ,+ 89:E<8=>?97 
 
Table 1: Percent of ARD/Labour between 1990-2017. *Refer to equation 3. 
Country Labour force 2017 (total working age) ARD/Labour in % (sum 1990-2017)* 
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Botswana 1131720 32,17 
Burkina Faso 6995457 5,29 
Cameroon 10499670 6,71 
Côte d'Ivoire 8015967 17,56 
Eswatini 466259 32,59 
Gabon 667636 7,11 
Kenya 19352405 15,66 
Malawi 8029723 19,52 
Mozambique 12898678 15,12 
Namibia 989579 17,45 
Nigeria 58958901 7,99 
Rwanda 6296321 6,88 
South Africa 22041176 19,75 
Tanzania 26306084 11,30 
Togo 3533538 5,15 
Uganda 15839805 17,29 
5. Methodology 
5.1 Panel data 
This thesis analyses cross-sectional and cross-temporal data with several observations per unit, 
hence a panel data analysis is conducted. The panel data covers the sample of 16 Sub-Saharan 
countries (table 1) over 28 years and includes several control variables in addition to the 
dependent variable and the variables of interest (section 5.2).  
      
We apply Driscoll-Kraay standard errors, an alternative to robust standard errors which is used 
with fixed effects regression. This alternative standard error is consistent even if there is 
heteroscedasticity, cross-sectional dependence and/or autocorrelation, issues which are 
indicated to be present in our model after running several tests (more on this in section 6.2). A 
fixed effects model is applied to control for endogeneity in individual or time factors that could 
bias the outcome.  
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5.2 Variables 
5.2.1 Dependent variable 
The aim of this paper is to evaluate if life expectancy at birth, as a measure for health, has had 
any significant effect on economic growth in Sub-Saharan Africa. Hence, the dependent 
variable is in accordance with prior studies related to the Gross Domestic Product (GDP) of the 
panel countries.  
      
This study utilizes GDP in constant local currency to measure the effect in real terms on GDP 
growth instead of in relative terms, as with the commonly used GDP per capita 
(GDP/population) measure (Kahende & Hoch, 2008; Bloom & Mahal, 1997; Dixon, McDonald 
& Roberts, 2001). By using constant local currency, the true growth of the series of 
observations is captured, i.e. the GDP is adjusted for the effects of price inflation by having a 
fixed base year.  
 
As with most of the variables used in this study, the natural logarithm is most appropriate to 
account for differences in the magnitudes of GDP between the subjected countries. Lastly, it is 
important to note that the dependent variable is, similarly to the independent variables, denoted 
as a differential to capture growth (equation 4).  
 
(4)     ∆𝑙𝑛𝑌 = 𝑙𝑛𝑌, − 𝑙𝑛𝑌,0/   
 
When choosing the dependent variable as being measured by GDP in constant local currency, 
instead of GDP per capita, a deviation from what has been common practice in the research 
area was made (see e.g. Lovász & Schipp, 2009; Kahende & Hoch, 2008; Dixon, McDonald 
& Roberts, 2001; Bloom & Mahal, 1997; Ashraf, Weil & Wilde, 2013). The justification 
behind this is that the study intends to look at the direct effect of ARD on GDP growth in 
absolute terms instead of in relative terms. If ARD had been used in combination with GDP 
per capita, there would have been a direct effect on the numerator which would perhaps cancel 
out the effect on the denominator, consequently biasing the possible causality between these 
variables.  
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5.2.2 Variable of interest 
As with previous studies in the area, a variable controlling for the health level of each nation is 
highly relevant as the hypothesis of this study relies on the assumption that changes in the 
wellbeing of people has a significant effect on the dependent variable. Different measures to 
account for health have been used before, such as human capital and health expenditures, which 
have the advantage of being quite comprehensive in their grasp, yet are difficult to obtain 
reliable data for and are in ways subjective (Dixon, McDonald, & Roberts, 2001; Kahende & 
Hoch, 2008). In accordance with Acemoglu and Johnson (2008), the measure used to account 
for health development is life expectancy at birth.  
 
Since the measure for health, life expectancy at birth, places more weight to recent years it is 
not a perfect measure for health in general, as it relies on the assumption that recent years better 
explain the present (WHO, 2006). This would in the case of extreme externalities, such as the 
outbreak of an epidemic or a civil war, skew the life expectancy at birth quite drastically and 
would thus be regarded as a weakness in the measure. For the purpose of this particular study 
however, this is rather seen as a strength as it highlights the effect of AIDS on GDP growth. 
Another positive aspect of the measure is that it is easily measured while also being relatively 
objective, making it one of the most frequently used measures. 
 
Although prior studies within the covered research area have commonly regarded the total 
number of HIV/AIDS-victims as their variable of interest, this paper focus solely on the number 
of AIDS-related deaths (Kahende & Hoch, 2008; Dixon, McDonald & Roberts, 2001; Bloom 
& Mahal, 1997). AIDS-related deaths affect mortality directly and is therefore more relevant 
since the health measure used in this study is, as aforementioned, life expectancy at birth (see 
section 2.2 for further discussion). The variable is adjusted to the same format as the dependent 
variable, expressed in equation 5 below. 
 
(5)     ∆𝑙𝑛𝑋 = 𝑙𝑛𝑋, − 𝑙𝑛𝑋,0/   
5.2.3 Solow input variables 
Since the model used is based on the theoretical framework of the Solow Growth Model, 
discussed in section 3.1, variables accounting for changes in capital and labour naturally had 
to be included. The aim was thus to use the capital stock for each nation starting at year 1990 
and add the capital investments for each year that followed, but because of data limitations this 
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measure could not be applied. Instead, a proxy for the capital stock, which still holds in the 
production function according to Solow’s theory, was used. Similar to Lovász and Schipp 
(2009), the capital investments in our regression models are operationalized by gross fixed 
capital formation (denoted as FCF). This variable describes the net capital investments in the 
capital stock in the production function for the Solow growth model.  
 
Next, data for total labour force was gathered for all 16 countries and 28 years, a 
straightforward measure denoted in absolute terms. Just as with the previous variables, these 
variables were adjusted as shown in equation 5. 
 
An important issue to be aware of is the endogeneity that capital investments could have in the 
model as it should display a β ≠ 0	and cov(𝐶𝑎𝑝𝐹, 𝐿𝑎𝑏𝑜𝑢𝑟) ≠ 0, which would suggest that the 
estimated marginal effect is not equal the true marginal effect 𝛽. The same applies for labour 
given the same conditions.  
5.2.4 Control variables 
In order to minimize omitted variable bias, additional relevant control variables were included. 
Seeing as the economies of the countries included in this thesis are dependent on commodity 
exports, a variable accounting for commodity price fluctuations was relevant to include. The 
commodity net export price index from the IMF was therefore used. This measure accounts for 
the different weights each commodity has in the specific country’s export and correlates this 
with the change in the international price of these commodities. Since the data is indexed to 
year 2012 a reindexing had to be conducted to the start year of this study, 1990, to more 
persistently show the effects of these price fluctuations. As data for two countries was missing 
for parts of the studied timeframe, these were approximated by looking at countries with 
comparable commodity export composition and applying an averaged index change to the 
countries with missing observations (section 4.1).  
 
Another control variable that was relevant to include was World GDP growth. By including 
this variable, any global economic growth fluctuations were made endogenous to the model.  
 
Table 2: Variables and respective descriptions. 
Variable Label Description Unit Year 
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Dependent 
variable 
        
lndiffGDP GDP in constant local 
currency 
Growth of GDP in 
constant local currency 
Natural log(%) 1991-2017 
Independent 
variables 
        
LifeExp 
  
Life Expectancy Change in life 
expectancy at birth 
Natural log(%) 1991-2017 
ARD 
  
Aids-related deaths Change in Aids-related 
deaths 
Natural log(%) 1991-2017 
CapF 
  
Capital Formation Change in Gross  Fixed 
Capital Formation 
Natural log(%) 1991-2017 
CapFLag 
  
Capital Formation, 
lagged 
See section 5.2.3. Natural log(%) 1992-2017 
Lab Labour Change in labour for 
working age population 
Natural log(%) 1991-2017 
LabLag Labour, lagged See section 5.2.3. Natural log(%) 1992-2017 
WorldGDP GDP growth World GDP growth for the 
World 
Natural log(%) 1991-2017 
CPC Commodity Price Change in Commodity 
Price 
%, Index (Base 
1990) 
1991-2017 
CPCLag Commodity Price, 
lagged 
See section 5.2.4. %, Index (Base 
1990) 
1992-2017 
      
5.3 Econometric model 
A regression analysis has been conducted for our econometric model, one basic followed by 3 
with modifications. The short model (equation 9) is constructed from the Solow growth model, 
and derived from the Cobb-Douglas production function as seen below in equation 6-8. The 
short model aims to evaluate how the economic growth has been affected by the proximate 
causes that the Solow model provides; capital, human capital, which includes life expectancy 
at birth or ARD, productive labour, and the error term 𝜀. For a detailed description of the 
notation of the variables in the following regressions see table 2.  
      
Here follows a derivation of the Cobb-Douglas production function leading to the model 
constructed for the purpose of this study, where i represents the cross-sectional dimension and 
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t the cross-temporal dimension. K stands for capital formation and H represents human capital 
which is captured mainly by health, ARD or life expectancy. AL is the productive labour force, 
where A is considered a constant in the model.  
 
(6)      𝑌+, = 𝐾+,-𝐻+,.𝐴𝐿+,/0-0.  
(7)   	𝑙𝑛𝑌+, = 𝛼 𝑙𝑛 𝐾+, 	+ 𝛽𝑙𝑛	(𝐻+,) + 1 − 𝛼 − 𝛽 𝑙𝑛	(𝐴𝐿+,) 
(8)   ∆𝑙𝑛𝑌+,=Δ𝛼𝑙𝑛 𝐾+, +Δ𝛽𝑙𝑛 𝐻+, + 𝛥 1 − 𝛼 − 𝛽 𝑙𝑛 𝐴𝐿+,  
 
As mentioned in section 3.1, life expectancy is assumed to capture health which is included in 
human capital H. ARD is in turn assumed to have a direct effect on H through its effect on life 
expectancy. Life expectancy at birth and AIDS-related deaths are both variables of interest in 
the study, and are respectively substituted with Δ𝛽𝑙𝑛 𝐻+, in the econometric model conducted 
for this study (equation 9-12). As mentioned, productivity A is accounted for as exogenous, a 
constant, and therefore not included in the applied model. An argument can be made that AIDS 
affects A as well, but since the focus for this thesis is health, we consider A to be a constant and 
only study the effect through H. To clarify that H is the variable of interest this term will be 
after the intercept coefficient in the regression in the following equations. The error term 
denoted by ε represents the unexplained effect on the dependent variable, that is, all that is not 
captured by the independent variables.  
 
(9)   ∆𝑙𝑛𝐺𝐷𝑃, = 𝛽^ + 𝛽/∆𝑙𝑛(𝐻,) + 𝛽_∆𝑙𝑛(𝐶𝑎𝑝𝐹,) + 𝛽`∆𝑙𝑛(𝐿𝑎𝑏,) + 𝜀, 
 
The calculation for the separate independent variables in the equation is explained by equation 
5. The two variables of interest will not be included in the same regression since they are 
expected to be correlated, and are both measures of health. We will present two sets of 
regressions for the model, one using life expectancy at birth and one using ARD, in order to 
see what effect each variable separately has on the dependent variable GDP growth.  
 
A modification to the short model is conducted by including the variables for capital and labour 
with a lag (equations 10-11). The lagged variables are included due to concerns regarding 
endogeneity in the model. It is important to note that although this helps to detect endogeneity 
in the model, it does not rule it out in any way. 
 
(10) ∆𝑙𝑛𝐺𝐷𝑃, = 𝛽^ + 𝛽/∆𝑙𝑛(𝐻,) + 𝛽_∆𝑙𝑛(𝐶𝑎𝑝𝐹𝐿𝑎𝑔,0/) + 𝛽`∆𝑙𝑛(𝐿𝑎𝑏𝐿𝑎𝑔,0/) + 𝜀, 
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(11)  ∆𝑙𝑛𝐺𝐷𝑃, = 𝛽^ + 𝛽/∆𝑙𝑛(𝐻,) + 𝛽_∆𝑙𝑛(𝐶𝑎𝑝𝐹,) + 𝛽`∆ln	(𝐿𝑎𝑏,) +																																				𝛽d∆𝑙𝑛(𝐶𝑎𝑝𝐹𝐿𝑎𝑔,0/) + 𝛽e∆𝑙𝑛(𝐿𝑎𝑏𝐿𝑎𝑔,0/) + 𝜀, 
 
To isolate the effect AIDS-related deaths and life expectancy at birth respectively have on 
economic growth, the long model which is an extension of the short model (equation 12), 
includes two additional control variables. The long model controls for World GDP growth and 
commodity prices, which both are expected to affect economic growth in the sampled Sub-
Saharan countries.  
 
(12)  ∆𝑙𝑛𝐺𝐷𝑃, = 𝛽^ + 𝛽/∆𝑙𝑛(𝐻,) + 𝛽_∆𝑙𝑛(𝐶𝑎𝑝𝐹,) + 𝛽`∆𝑙𝑛(𝐿𝑎𝑏,) +																																				𝛽d∆ln	(𝐶𝑎𝑝𝐹𝐿𝑎𝑔,0/) 	+ ∆𝑙𝑛(𝐿𝑎𝑏𝐿𝑎𝑔,0/) + 𝛽f∆𝑙𝑛(𝑊𝑜𝑟𝑙𝑑𝐺𝐷𝑃,) +																																				𝛽i∆𝑙𝑛𝐶𝑃𝐶, + 	𝛽j∆𝑙𝑛𝐶𝑃𝐶𝐿𝑎𝑔,0/ + 𝜀 
6. Results 
6.1 Regression results  
In this section, we will present the results from our econometric model, with all its 
specifications. The purpose of these 8 regressions is to see if the results hold to explain how 
life expectancy affects economic growth in the 16 selected Sub-Saharan countries. The number 
of observations vary from 432 to 416 due to lagged variables in model 2-4 and 6-8 (seen in 
tables 3 and 4). We accept a significance level of 10%.  
 
The two variables of interest used, life expectancy at birth and AIDS-related deaths, are 
estimated and illustrated in individual regression tables (table 3 and 4, seen below). Each of 
these use the same control variables, specifications and both have GDP in constant local 
currency as the dependent variable. The short model is labelled as model 1 and 5 respectively, 
with modifications for lag in model 2-3 and 6-7. The long model of the regressions is labelled 
model 4 and 8 respectively. The results are explained below and presented in table 3 and 4. 
Firstly, we explain the results in the regression table 3 where life expectancy at birth is used as 
the variable of interest, then follows the results for the regressions with AIDS-related deaths as 
the variable of interest, seen in table 4.   
 
Firstly, in model 1, represented by equation 9, life expectancy at birth is significant at a 10% 
significance level. The coefficient for life expectancy at birth 𝛽/	is positive and indicates that 
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generally in the sample countries, a 1% increase in life expectancy at birth is associated with 
an increase in GDP growth of 0.245%. The inputs capital and labour are both positive, labour 
has a quite high coefficient but is not significant, whereas capital is significant at a 5% 
significance level and its coefficient is at a level of 0.117.  
 
When using lagged control variables, we capture the dynamic in the model and take the fact 
that previous years possibly affect the next year into consideration. In these specifications, 
model 2 and 3, life expectancy at birth is significant even at a 5% level. Capital and labour are 
not statistically significant when they are lagged which indicates that the previous year does 
not have a significant effect on the GDP growth of the following year. In model 3 (equation 
11) where capital and labour are included both in lagged form and not, capital displays a lower 
p-value. The adjusted R-squared is reduced to 0.064 in model 2 when including lagged 
variables. Hence, this specification to the short model does not explain the dependent variable 
in the same extension as model 1, without lagged variables, does. Model 3 on the other hand 
increases the R-squared value, providing a better explanation to the outcome.  
 
Finally, the long model (model 4, equation 12) shows a significant effect on life expectancy at 
birth at a 5% significance level. The coefficient 𝛽/ is interpreted as increasing the outcome 
variable GDP growth with 0.289% when life expectancy at birth increases with 1%. As in 
previous regressions for the short model, labour is not significant and capital is significant at a 
5% significance level.  
 
World growth is controlled for in the long model and is significant at a 1% significance level, 
its coefficient 𝛽f indicates an increase of 0.628% in GDP growth for the sample countries when 
the world growth increases with 1%. Commodity prices is included in the long model, both 
lagged and not, neither is significant at the accepted rejection level for this thesis. The 
coefficient for commodity prices are estimated to be negative when not lagged, and positive 
when lagged.  
 
In the long model, we find the highest R-squared value, comparing the model specifications 
with life expectancy at birth as the variable of interest. This indicates that the inputs in the long 
model are important to add to better explain the outcome, economic growth. 
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Table 3: Models with life expectancy at birth as variable of interest, regressed on GDP (Constant Local 
Currency) 
 
 
 
When including ARD as the variable of interest (table 4), the short model specification (model 
5, equation 9), shows that the variable of interest is insignificant at the 10% level, although 
with a p-value of 0.103. A negative coefficient is estimated in line with what a direct effect of 
increased mortality should result in. This would indicate that an increase in ARD would lead 
to a decrease in GDP growth. When lagged, ARD was still estimated as insignificant as shown 
in table A2 in the appendix. Both capital and labour in model 5 are significant at a 5% 
significance level and the coefficients indicate a positive effect on the dependent variable. 
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Labour displays a relatively strong coefficient of 0.9, while the coefficient on capital is weaker 
at 0.114.  
 
Moving on to the second specification, namely model 6 (equation 10), where labour and capital 
are included in a lagged form. The p-value of the variable of interest, ARD, increases slightly 
in this specification, compared to model 5. In addition, the results show that the lagged 
variables are non-significant at any relevant rejection level. This means that the lagged 
variables do not have any statistically significant impact on the non-lagged dependent variable, 
namely GDP growth. Lastly, the R-squared value of 0.072 is lower when running this particular 
specification, relative to the other specifications, indicating that the inputs are less informative 
about the outcome.  
 
In model specification 7 (equation 11), the p-value of ARD increases yet again to 0.159, but 
the coefficient stays negative at approximately the same level as earlier specifications. Both 
the non-lagged- and lagged variables for capital and labour are included here. Just as in model 
5, the variables are significant at a 5%-level while the lagged variables are non-significant as 
in model 6. Nonetheless, it is interesting to discern the fact that the coefficients as well the p-
values of most of the independent variables change quite substantially as compared to previous 
specifications. The signs in front of the coefficients are however kept intact.  
 
To conclude, model 8 (equation 12) is the long specification of the model which includes an 
additional 3 control variables. Here, the p-value of the variable of interest drops to 0.104, and 
is thus, just as in model 5 randomly deviated from the 10% significance level. In comparison 
to model 7, the main difference relates to the added variables, although the labour variable does 
become less significant reaching only a 10%-significance level. The World GDP growth 
variable is estimated to be significant and has a positive coefficient. The commodity price 
variable estimates a negative coefficient, but is insignificant at the 10% level. A final remark 
is that the R-squared value for model 8 is the highest amongst all (model 1-8), signalling that 
its inputs explain the outcome, economic growth, better than the other specifications. 
 
Important to note is that the p-value for the variable of interest ARD lies just above the 10% 
significance level in all four specifications and has similar coefficient estimates. Being this 
close to the chosen critical value level, no conclusions can be drawn as this deviation should 
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be seen as random, small changes or improvements in data would likely make the variable 
significant at the 10% level.  
 
Table 4 - Models with ARD as variable of interest, regressed on GDP (Constant Local Currency) 
 
 
6.2 Sensitivity analysis  
To choose specification of the model, a Hausman test was conducted using the original short 
model specification A (appendix, table A1). The null hypothesis is that the individual-level 
effects of the estimators are adequately modelled by a random-effects model. Results show that 
the null hypothesis is clearly rejected at the 5% significance level, meaning that a fixed-effects 
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model is more appropriate to apply in this case. Random effects model has stronger demands 
on exogeneity and is therefore not appropriate for macro-level models, as the one in this study. 
The fixed effects model captures unobservable variables which change over time. This is of 
high importance since the countries included are heterogeneous in the aspect of for example 
institutions, social policies and weather, all factors which could influence the economic growth 
in each country differently.  
 
Heterogeneity between ARD and labour is to be expected as both 𝛽 ≠ 0	and 𝑐𝑜𝑣(𝐴𝑅𝐷, 𝐿𝑎𝑏𝑜𝑢𝑟) ≠ 0, an increase in ARD would naturally lead to a decrease in labour. 
Hence, multicollinearity is possibly present when including ARD together with labour. 
Multicollinearity can lead to skewed results since it may create a wider confidence interval. 
Subsequent, type 2 errors are likely to occur, resulting in failure to reject a false null hypothesis. 
However, multicollinearity does not interfere with the predictive power of the outcome in the 
model as a whole, but solely with the coefficient to the variables which have an interacting 
effect between them, which ARD and labour are expected to have in this study. This is possibly 
a reason why ARD is only close to significant in the regression when using it as the variable of 
interest. The insignificance can also be a consequence of insufficient data or low aggregated 
ARD in certain countries (section 4.2). ARD would possibly be significant had we only 
included countries with higher aggregated ARD than the used limit of 5%.  
 
Omitted variable bias is expected in the short model specifications, model 1-3 and 5-7. This is 
the model in its simplest form and omitted variable bias is assumed to be present as relevant 
variables are excluded. In the long model, model 4 and 8, the higher R-squared values provide 
evidence that the additional control variables, world growth and commodity prices, are 
important inputs to explain the outcome. By including additional variables, the risk of omitted 
variable bias can be reduced.  
 
In order to check for differences in the statistical dispersion of the variables included, a test for 
heteroscedasticity was conducted. The modified Wald test for groupwise heteroscedasticity in 
fixed effect regression models was the most appropriate and it clearly showed that a null 
hypothesis of homoscedasticity had to be rejected. Although not surprising, seeing as there are 
many potential exogenous country-specific factors which could alter variance, it is something 
that had to be dealt with since failing to do so could invalidate any statistical inference from 
our model.  
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Furthermore, a Breusch-Pagan LM test of cross-sectional dependence was conducted to control 
for any interdependencies between the cross-sectional units estimated in the panel data 
regressions (see appendix tables A3 and A5). A test best suited when T>N, meaning that the 
time dimension is larger than the cross-sectional dimension (De Hoyos & Sarafidis, 2006), 
which is the case in this study. The importance of this is emphasized by Hoechle (2007), who 
argues that “erroneously ignoring cross-sectional correlation in the estimation of panel models 
can lead to severely biased statistical results.”, and states that this has been a commonly ignored 
aspect amongst practitioners. De Hoyos and Sarafidis (2006) also discuss this, and point to the 
fact that cross-sectional dependence is likely to be exhibited in the errors of panel data models 
due to common shocks being present together with unobserved components, which ultimately 
become part of the error term.  
 
Results from the Breusch-Pagan LM test show that there is in fact cross-sectional dependence 
as the null hypothesis of there being no cross-sectional dependence is rejected at all significance 
levels. Finally, a modified Wald test for groupwise heteroscedasticity in fixed effect regression 
models (see appendix tables A4 and A6) was conducted to check for potential presence of 
heteroscedasticity in the variance of the variables. The null hypothesis was again rejected in 
this test, stating that there is an absence of homoscedasticity. In order to minimize the bias on 
the standard error that both the heteroscedasticity and contemporaneous correlation cause, 
Hoechle (2007) suggests that Driscoll & Kraay standard errors should be used. Developed by 
Driscoll & Kraay (1998) as a “nonparametric covariance matrix estimator which produces 
heteroscedasticity consistent standard errors that are robust to very general forms of spatial and 
temporal dependence.”. As cited, it does not only control for the issues proven to be present, 
but also autocorrelation, which is assumed to be present to some extent in our model. Tables 
A9 and A10 test for autocorrelation in the two independent variables, and results show that 
there is a clear degree of serial correlation present at least for ARD.  
7. Discussion 
When health declines and affects adults, it will naturally have a direct negative effect on 
economic growth through the loss of productivity due to illness and/or death. This thesis 
concentrates on the health measure life expectancy at birth which does not account for how 
subjectively healthy the population was during their lifetime. Omitted variable bias may be 
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present since we do not account for how the time of illness affected growth. To adjust the model 
for this endogeneity problem, a more detailed analysis on health expenditures, productivity loss 
and welfare system would be required, as well as an analysis of other health measures. It is 
possible that the results would have been slightly different if another measure for health was 
applied, this would however entail making more subjective assumptions in constructing the 
measure (e.g. human capital).   
 
AIDS takes lives from all age cohorts, which Acemoglu and Johnson (2005) claimed was a 
possible reason why the AIDS epidemic would impact growth negatively, in contrast to other 
mortal diseases which mainly affect children and elderly. The dependency ratio is one of the 
mechanism that can be used to confirm that AIDS affects growth negatively due to its increase 
in adult mortality. A reduction in the working-age cohort leaves the society unbalanced with a 
redundancy of children and elderly, giving the productive adults more people to provide for. In 
such a scenario, economic growth is expected to decrease, as the results in this thesis with ARD 
as the variable of interest shows (table 4). ARD is close to significant at our acceptable rejection 
level 10%, with a p-value of 0.104 in the long model, and it can therefore at least be assumed 
that the estimated coefficient has the correct sign, negative. With only 0.004% from 
significance, it is possible that with additional and/or improved data, ARD would have been 
significant.  
 
Young (2005) estimated that the dependency ratio would decrease due to less people in all age 
cohorts when analysing the AIDS epidemic. However, the positive effect that Young estimated 
this would have on economic growth is not supported by this thesis since the results show a 
negative effect on economic growth. Hence, according to the results in this study, the effect 
from the reduction in productive adults is stronger than the effect of the reduction of population 
overall, which would result in extra resources relative to population. The prospects of improved 
growth that Young presented is however possible, but first when the epidemic settles. The high 
fertility, estimated by Lorentzen, et al. (2008), and sudden fall in mortality when ART is 
introduced will create a large future working-age cohort in comparison to elderly. In such a 
scenario, the dependency ratio would fall as Young (2005) estimated. Bloom and Canning 
(2008) discussed that in a situation with a decreasing dependency ratio, the region may achieve 
demographic dividend. To properly confirm this statement a more detailed analysis of the 
demographic change post the epidemic would have to be conducted.  
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The almost significant estimated coefficient for AIDS-related deaths (section 6.1) indicate a 
negative effect on growth, which can also be a consequence of the change in behaviour that 
adult mortality is associated with, in accordance with Lorentzen, et al. (2008). Death at the 
peak of the productive years is associated with riskier behaviour, higher fertility and lower 
investment rates, both for physical capital and human capital accumulation (Lorentzen, et al. 
2008). Young (2005) also discussed how the behaviour of people changed during the worst 
years of the HIV/AIDS epidemic. In contrast though, the author found that there was a 
reduction in fertility which would have a positive impact on economic growth due to a 
redundancy of resources per capita, this is as stated, not supported by the results in this study. 
Even though ARD alone was only almost significant, we do expect it to be correlated with life 
expectancy which in turn has a statistically significant effect on economic growth. Hence, 
AIDS is assumed to have reduced life expectancy at birth and in extension therefore also 
decreased economic growth in Sub-Saharan Africa.  
 
AIDS does not only affect productive adults though, children are infected by the virus as well. 
Children are one of the important sources to major reductions in life expectancy at birth. Death 
in early ages has a large impact on this particular health measure, since it is a calculation of the 
average years a new-born is expected to live (OECD 2017). The loss of children/infants does 
not cause a direct loss in productivity. Notwithstanding the fact that it does affect the future 
standards of living which Young (2005) discussed. 
 
Life expectancy at birth is expected to have positive coefficients, as it does in our model, 
associating it with a positive effect on GDP growth. Life expectancy at birth is, as mentioned, 
significant in all the models, but since the R-squared value is highest in the long model (model 
4) it is the one considered to explain the outcome the most. A decrease of 1% in life expectancy 
at birth is associated with a decline in GDP growth with 0.289% according to model 4. 
 
In Botswana, the decrease of 21% in life expectancy at birth during the worst years of the 
epidemic, 1990-2001, mentioned in section 2.1, would then imply a decline in GDP growth of 
6.07%. The followed increase in life expectancy from 2001-2017, partially expected to be due 
to ART, would according to our results have increased GDP growth with 10.6%. We cannot 
conclude that AIDS bore the full responsibility for the decline, though it is expected to be partly 
liable. Since ARD is not significant in our model, its estimated coefficient is not analysed 
further than having a negative impact and the impact it has through life expectancy at birth.  
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Lovász and Schipp (2009) estimated a 2% decline in GDP growth per year associated with the 
HIV/AIDS epidemic in Sub-Saharan Africa. Lovász and Schipp (2009), Over (1992) and 
Lorentzen et al. (2005) claimed that HIV/AIDS is accountable for the growth tragedy in Africa 
(section 3.3). The authors stated that in a scenario without HIV/AIDS, the economic growth in 
the region would be more similar to South and East Asia. This statement was validated by the 
model applied in this thesis, as it showed that ARD did explain a major part of the decrease in 
life expectancy in the sample countries, which subsequently had a negative effect on economic 
growth.  
 
Acemoglu and Johnson (2007) discussed that omitted disadvantages in low developed 
countries, which affect economic growth and health, are present, and therefore causality cannot 
be established. HIV/AIDS affects high-income countries as well, but not to the same extent as 
low-income countries. In low-income countries as this study covers, the lack of information 
about the spread of HIV/AIDS and the lack of funds to provide treatment to the population are 
two major disadvantages which cause the epidemic to be more severe. Anyone could become 
infected, though the probability is higher in developing countries and the treatment is not as 
accessible, subsequent, there will be more AIDS-related deaths. Reversed causality and/or 
omitted disadvantages can therefore not be excluded when using AIDS as a natural experiment. 
The omitted disadvantages which are discussed by Acemoglu and Johnson (2007) causes 
possible reversed causality and the results of this thesis must therefore be considered with 
cautious.  
 
Considering that the world is continuously becoming more globalised and interdependent on 
multilateral trade, price fluctuations were hypothesized to have a measurable effect on GDP 
growth for the selected Sub-Saharan countries. Surprisingly however, estimates retrieved on 
this variable were not significant even on a 10% significance level, yet had as predicted a 
negative coefficient. 
 
The secondary data sources, from where the data for this thesis has been collected, World Bank, 
IMF and UNAIDS, are all well-established and recognized amongst prior studies, they should 
therefore be viewed as reliable. However, in low-income countries, as those this report studies, 
the primary data which the countries report to the secondary sources is not assured to be of 
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high quality. This is due to the risk of being affected by the quality of the government 
accounting systems and the level of corruption in the country (World Bank, 2019). 
 
The data on AIDS-related deaths are also in risk of being faulty due to incorrect reports about 
causes of deaths or even the lack of any reports on deaths. In this aspect, the thesis faces 
limitations which compromises the truthfulness of the result.  
8. Conclusion 
The main purpose of this thesis was to analyse if life expectancy at birth has an effect on 
economic growth. In a separate model specification, the assumed exogenous effect that AIDS 
has had on life expectancy in Sub-Saharan Africa is used as a natural experiment and its effect 
on economic growth is estimated.  
 
As the statistical significance of AIDS-related deaths randomly deviated from the chosen 10%-
significance threshold, one careful conclusion that can be drawn is that AIDS did indeed cause 
a decrease in GDP growth in the sampled countries. A significant effect that we on the other 
hand can establish, is that the decline in life expectancy from 1990 until early 21st century 
decreased economic growth in Sub-Saharan Africa. We do not however claim causality due to 
endogeneity issues, as discussed in section 2.2. Yet given the assumptions made in this thesis, 
the results do show a relationship between life expectancy and economic growth. When 
comparing the model specifications, the importance of the control variables role to explain the 
outcome is made visible. The long model has the highest R-squared value and world growth is, 
as expected, an essential and statistically significant input to explain the outcome.  
 
The discussed reasons behind the findings include productivity loss, demographic change and 
change in behaviour, mainly in a disfavouring way of economic growth, these are supported 
by previous work within the research area. When life expectancy at birth declines due to ARD, 
people tend to invest riskier, have more children and human capital accumulation declines, 
which is generally negatively associated with economic growth. Having obtained these 
findings, we can hereby respond to the research question in the introduction with the following. 
Yes, according to the results of this thesis, and given its assumptions, life expectancy does 
affect economic growth in Sub-Saharan Africa. In consent with Over (1992) and Lovász and 
Schipp (2009), it is very likely that Sub-Saharan Africa would have experienced another growth 
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development if the region had not been a victim of health issues which decrease life expectancy, 
such as the AIDS epidemic.  
 
One of the main strengths of this study was the time-dimension which, in comparison with 
previous research in the area, was able to capture both the increase, peak, and subsequent 
decline of ARD in the Sub-Saharan region. In addition to this, the study also differentiates itself 
by applying a more direct measure to capture the impact of the HIV/AIDS-epidemic, by 
looking at the number of deceased AIDS victims instead of a more general HIV prevalence 
measure. 
 
Despite these strengths, it is important to note that several areas can be improved upon and 
complemented in further research. One obvious way to develop the study would be to extend 
the cross-sectional dimension by including more countries. Another way could be to look at 
other pandemics which have severely affected productivity in the afflicted countries through 
increased mortality and decreased life expectancy. By doing so, a more generalizable 
conclusion may be reached. Lastly, future research could also complement this thesis by 
looking at the post-epidemic long-term effects of life expectancy on economic growth, by 
extending the time-dimension.  
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10. Appendix  
 
Table A1: Hausman test 
 
 
 
 
 
Table A2: Effect on Life expectancy from ARD 
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Table A3: Breusch-Pagan LM test for cross-sectional dependence (Life Expectancy at birth) 
 
 
 
 
Table A4: Test for heteroscedasticity (Life Expectancy at birth)  
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Table A5: Breusch-Pagan LM test for cross-sectional dependence (ARD) 
 
 
 
 
Table A6: Test for heteroscedasticity (ARD) 
 
 
 
 
Table A7: ARD t-1 and t-2 
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Table A8: Life expectancy t-1 and t-2 
 
 
 
Table A9: Autocorrelation life expectancy 
 
 
 
Table A10: Autocorrelation ARD 
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